524768 — Emmessar Biotech and Nutrition Income Statement
0.000.00%
Last trade - 00:00- IN₹161.62m
- IN₹90.21m
- IN₹6.11m
Annual income statement for Emmessar Biotech and Nutrition, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 69.9 | 3.65 | 10.2 | 5.55 | 6.11 |
| Cost of Revenue | |||||
| Gross Profit | 34.6 | 2.39 | 6.19 | 3.57 | 4.29 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 62 | 13.5 | 18 | 17.3 | 16.6 |
| Operating Profit | 7.89 | -9.87 | -7.84 | -11.8 | -10.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 22.5 | 9.31 | 9.67 | 8.13 | 9.58 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 14.5 | 4.75 | 5.04 | 7.5 | 3.16 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 14.5 | 4.75 | 5.04 | 7.5 | 3.16 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 14.5 | 4.75 | 5.04 | 7.5 | 3.16 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.9 | 0.951 | 1.01 | 1.5 | 0.633 |
| Dividends per Share |